Background: Concentrations of physiological response variables fluctuate over time. The present study describes within-day and seasonal fluctuations for total cholesterol, dehydroepiandrosterone sulfate (DHEA-S), hemoglobin A 1c (HbA 1c ), IgA, prolactin, and free testosterone in blood, and estimates within-(CV i ) and between-subject (CV g ) CVs for healthy women. In addition, the index of individuality, prediction intervals, and power calculations were derived. Methods: A total of 21 healthy female subjects participated in the study. Using a random effects analysis of variance, we estimated CV g and total within-subject variation (CV ti ), i.e., the combined within-subject and analytical variation, from logarithmically transformed data. Analytical variation was subtracted from CV ti to give CV i . CV i was estimated from samples taken monthly during 1 year (CV iy ), weekly during 1 month (CV im ), and six times within 1 day (CV id ). Results: A cyclic seasonal variation was demonstrated for total cholesterol, DHEA-S, HbA 1c , prolactin, and free testosterone. Within-day variation was shown for prolactin and free testosterone. The overall mean values for the group and the variability (CV iy and CV g ) were: 5.1 mmol/L, 5.5%, and 5.0% for total cholesterol; 6.6 mol/L, 7.1%, and 21% for DHEA-S; 4.3%, 2.6%, and 3.3% for HbA 1c /hemoglobin total ; 2.1 g/L, 5.9%, and 13% for IgA; 136 mIU/L, 23%, and 27% for prolactin; and 5.4 pmol/L, 21%, and 29% for free testosterone.
make it easier to optimize future interventions. The planning and interpretation of measurements of early response variables in intervention requires knowledge of biological variation. The response variables selected in the present study, total cholesterol, dehydroepiandrosterone sulfate (DHEA-S), hemoglobin A1c (HbA 1c ), IgA, prolactin, and free testosterone, were included because the increased psychosocial stress of contemporary society may contribute to changes in concentrations of these response variables.
Diurnal variation has been described previously for DHEA-S, prolactin, and testosterone in healthy elderly women (5 ) . Seasonal variation has been shown previously in women for DHEA-S (5 ) and prolactin (6 ) , whereas other studies have failed to demonstrate seasonal variation for prolactin (5, 7 ) and testosterone (7 ) . Data on within-and between-subject variation for healthy individuals for several clinically relevant response variables have been compiled by Sebastian-Gambaro et al. (8 ) . However the data compiled for DHEA-S, HbA 1c , IgA, and prolactin cover only a time span of up to 24 weeks, and data for free testosterone are not available.
The aim of the present study was to provide data on biological variation including diurnal and seasonal variation for total cholesterol, DHEA-S, HbA 1c , IgA, prolactin, and free testosterone in healthy females, and in addition, to present within-subject variation for time spans of 1 day, 1 month, and 1 year, together with other useful statistics derived from measures of variation: Ii, prediction intervals, and power calculations necessary for planning future studies. The intention is to provide tools useful for design of studies of individuals in clinical settings and studies of groups of individuals.
Subjects and Methods study groups
The study was carried out in Copenhagen, Denmark, with two different study groups: group A [n ϭ 12; mean age, 35 years (range, 26 -44 years); mean height, 170 cm (range, 163-178 cm); mean weight, 70 kg (range, 54 -87 kg)] and group B [n ϭ 10; mean age, 25 years (range, 20 -31 years); mean height, 168 cm (range, 157-176 cm); mean weight, 61 kg (range, 51-68 kg)]. Both study groups consisted of healthy, premenopausal women from a research environment undertaking their routine life-style. There were nine and seven nonsmokers in study groups A and B, respectively. Exclusion criteria were pregnancy, lactation, and use of contraceptive pills or other forms of hormonal medication. On each day of blood sampling, all participants answered a questionnaire on personal characteristics, including number of days since the first day of the last menstrual cycle. However, blood sampling was not standardized with respect to menstrual cycle. One person (nonsmoker) from study group A was later excluded from analysis because of pregnancy; the statistical analysis was accordingly carried out for n ϭ 11 subjects. All subjects gave informed consent, and the local ethics committee approved the study to comply with the Helsinki Declaration.
design For investigation of within-year variation, a total of 12 blood samples from each subject in study group A (n ϭ 11) were obtained between 0900 and 1100 once a month during 1 year (June 1995 to May 1996). For the same study group (A), a total of five samples were collected once a week within 1 month for investigation of within-month variation. For investigation of within-day variation, a total of six blood samples from each subject in study group B (n ϭ 10) were obtained on 1 day between 0900 and 1800 (May 1996 to June 1996). The subjects in this group were seated the whole day with a short walk once every hour.
sample preparation
Blood was collected from the antecubital vein by venipuncture in 10-mL Vacutainer ® tubes (Becton Dickinson). Samples for HbA 1c analysis were collected in tubes containing EDTA. Samples for total cholesterol, DHEA-S, IgA, prolactin, and free testosterone were collected in plain tubes with no additives and after 2 h at room temperature were centrifuged 10 min at 1731g. Serum was separated from the sediment and stored frozen (Ϫ20°C) for 2-12 months until assayed.
chemical analysis
Samples for analysis of total cholesterol, DHEA-S, and IgA were held and analyzed in a few assays within 6 weeks. Analysis of HbA 1c , prolactin, and free testosterone was carried out within 2 months of sample collection because the response variables were stable for that period. In all cases, samples were analyzed in the order they were collected.
The HPLC system for the analysis of HbA 1c consisted of a Waters 625 LC system together with a Waters photodiode array detector model 996 and a WISP 717 autosampler for automatic injection of the samples. Millennium chromatography software was used for calculation of concentrations (Waters Associates). A cation-exchange Mono S HR 5/5 column from Pharmacia Biotech was used to separate HbA 1c from other components in the samples. A competitive enzyme immunoassay in 96-well MaxiSorp Nunc-immuno plates (Nunc) was used to determine DHEA-S in serum. Each well was incubated overnight at room temperature with a saturated solution of DHEA-albumin (Steraloids) diluted (1:10 000) in phosphate-buffered saline, pH 7.3. The plates were washed in wash buffer (phosphate-buffered saline containing 0.5 mL/L Tween 20), and 50 L of diluted (1:2000) DHEA-S calibrators in the range of 1.4 -24 mol/L or samples were applied to wells in duplicate together with 50 L of diluted (1:5000) sheep anti-DHEA-S antiserum (Guildhay) and incubated for 1 h at room temperature with shaking. After washing, the retained antibody was incubated 1 h with peroxidase-conjugated anti-sheep immunoglobulin antibody (Dako A/S). 2,2Ј-Azino-di-(3-ethyl-benzthiazoline)sulfonat-6-diammonium salt (Boehringer Mannheim) was used as a chromophore (9, 10 ) , and color development was measured with a microtiter plate photometer (R-400 Sfc; SLT Labinstruments). MultiCalc, Ver. 2.0, software from Wallac was used for calculation of concentrations. According to the manufacturer, the anti-DHEA-S antibody exhibits full cross-reactivity to DHEA, some cross-reactivity to androstenedione (Ͻ10%), and Ͻ1% cross-reactivity to all other steroids tested. DHEA-S purchased from Sigma was used for calibration. The RIAs used for determination of free testosterone and prolactin in serum were Coat-a-Count kits purchased from Diagnostic Products. A 1470 Wizard gamma counter from Wallac was used for measurement of radioactivity. Immunoturbidimetric analysis for determination of IgA and colorimetric determination of total cholesterol were carried out in a COBAS Mira Plus (Roche Diagnostic Systems). The assays used were UNIMATE 3 for IgA (cat. no. 07 3696 1) and UNIMATE 5 for total cholesterol (cat. no. 07 3663 5), both from Roche Diagnostic Systems.
The following commercially available quality-control materials were used: Con6 Immunoassay Tri-level Controls from Diagnostic Products (DHEA-S, prolactin, and free testosterone); Lyphochek Diabetes Control from Bio-Rad for HbA 1c ; Human Serum High and Low Control from Dako (IgA); and Human Serum Control N for Cobas from Roche (total cholesterol).
quality assurance
The analytical methods for measurement of DHEA-S and IgA had been evaluated by a method evaluation function design according to Christensen et al. (11 ) to estimate the random and systematic effects. The method evaluation function was based on a linear least-squares regression analysis of the measured concentration vs the conventional true concentration of a series of method evaluation samples containing the physiological response variable in the linear range of the method. No statistically significant systematic effects were found for the DHEA-S method, whereas the IgA method had a bias of 4.7%. DHEA-S purchased from Sigma was used for method evaluation. Different batches were used for calibration and method evaluation. According to the manufacturer, the water content (Karl Fischer method) of both batches was 8.2%, and the purity as determined by thin layer chromatography was Ͼ99.5%. The HbA 1c method had been evaluated by interlaboratory comparison based on 17 patient sam-
denotes the slope and a denotes the intercept, was estimated and the approximate SD of the estimates of a and b were calculated (12 ) . The analysis allowed for adjustment of differences in variation of the two different analytical methods by use of the factor ϭ y 2 / x 2 . Based on the functional model, there was no statistically significant difference between the two laboratories. The kit for free testosterone had been compared by the manufacturer to a conventional equilibrium dialysis method using 42 serum samples from female subjects. Linear regression analysis yielded the following components: (Diagnostic Products kit) ϭ 0.79(dialysis) ϩ 1.0 ng/L. No information on traceability was given. According to the manufacturer, the kit for measurement of prolactin was traceable to the WHO First International Reference Preparation of Human Prolactin for Radio-immunoassay, no. 75/504 (1st IRP 75/504) and Third International Standard for Prolactin, no. 84/500 (3rd IS 84/500). The following conversion factor was given: 1 g ϭ 26 mIU of prolactin. An evaluation based on the "Guide to the Expression in Uncertainty of Measurement" (GUM) concept has been carried out for the prolactin RIA method (13 ) .
To show equivalence between different analytical runs, commercially available control samples for the specific physiological response variables were analyzed together with samples. Westgaard control charts were used to document that the analytical methods remained in analytical and statistical control, i.e., the precision and the trueness of all the analytical methods remained stable. An ongoing monitoring of the analytical performance against the norm of other laboratories was provided by participation in the following external quality assessment schemes by Labquality (Helsinki, Finland): Hormones and other immunochemical determination (DHEA-S, IgA, prolactin, and free testosterone), and Glycated hemoglobin (HbA 1c ). The target values used for evaluation of the laboratory performance were calculated as the means of all methods after exclusion of outliers (greater than Ϯ 3 SD). Furthermore, an evaluation was provided based on grouping of the analytical methods.
statistics
Statistical analysis was carried out using SAS ® System TM , Ver. 6.12 (SAS Institute). AMIQAS was used for method evaluation and internal quality control (14 ) .
Test for outliers. Cochran's criterion test was used to test for outliers in the variances within the subjects (15 ) . In six cases, a high within-subject variance was identified. The single-Grubb's test and double-Grubb's test (15 ) were applied to the measurements of the subjects with high variance to detect any outlier observations. In three cases, the high within-subject variance was explained by a single outlier, which was subsequently excluded from the analysis. In three cases, no measurements could be identified as outliers and the whole set of measurements was included in the analysis.
Statistical model. The data were tested for log-normal distribution and consequently were logarithmically transformed before statistical analysis. Data were analyzed using a variance component model with subject as random effect by use of the Mixed procedure in the SAS System. Variance components describing variation be-Clinical Chemistry 46, No. 4, 2000 tween individuals (V g ), and total within-subject variation (V ti ), i.e., variation within individuals combined with analytical variation, were estimated. The latter includes unexplained variation. Pearson correlation coefficients were calculated using averages for each individual.
Seasonal and within-day variation. For analysis of periodic variation over the year (study group A), a parametric model, cyclic over the year using sine and cosine, was included. In this case, the within-subject variation may be reduced depending on the fit of the parametric function. Data were analyzed for periods of 6 and 12 months. For description of the variation between 0800 and 1800, a repeated-measures general linear model (GLM) was used for analysis of within-day variation after grouping measurements into morning (0900 -1000), midday (1200 -1400), and afternoon (1500 -1800).
Biological variation. Variance components were calculated for blood samples taken within 1 year, within 1 month, and within 1 day. Where nothing else is stated, the calculations are based on results from samples taken during 1 year. The total within-subject variability (CV ti ) and the between-subject variability (CV g ) were estimated as the square roots of the respective variance component estimates. Estimates of the analytical variation (CV a ) were based on logarithmically transformed data of control samples from the analytical runs in which the samples were measured. The concentrations of the response variables in the control samples were within the range of individual average concentrations. The within-subject variability (CV i ) was calculated for 1 day (CV id ), 1 month (CV im ), and 1 year (CV iy ) by subtraction of the analytical variation using the general formula: CV i ϭ ͌ CV ti 2 Ϫ CV a 2 . CV ti includes, and therefore ideally should exceed, the analytical variation. In case the estimated CV ti was less than CV a , CV i was given as less than the upper value of the 99% confidence interval for the estimate of CV i .
We have followed common practice in this report, and calculated Ii as CV ti /CV g , despite the semantic problem of the index being small when there are large differences between individuals, as pointed out by Fraser and Harris (3 ) . Prediction intervals for the concentration of a future sample taken from the same woman based on a single measurement were calculated using the formula: 1.96 ϫ ͌ 2 ϫ CV ti . Prediction intervals are expressed in percentages because the underlying distribution is log-normal. The minimal detectable differences (MIDEDIF) obtainable at the 5% significance cutoff with the power 0. 
Results
In Fig. 1 , the average concentrations Ϯ SD of the measured physiological response variables are plotted for all subjects in study group A. The average concentrations of DHEA-S and free testosterone were positively correlated between subjects [correlation coefficient () ϭ 0.64; n ϭ 11]. Concentrations of DHEA-S were negatively correlated with concentrations of HbA 1c ( ϭ Ϫ0.73). No systematic relationships were found when concentrations of the selected response variables or residuals from the model were evaluated against the number of days since the last menstrual cycle.
The seasonal variations for total cholesterol, DHEA-S, HbA 1c , prolactin, and free testosterone are shown in Fig.  2 . The concentrations of HbA 1c (P Ͻ0.001) and DHEA-S (P ϭ 0.002) exhibited a cyclic variation with a period of 6 months. The HbA 1c concentrations were highest in September-November and March-May (4.4% of total hemoglobin) and lowest in June-August and December-February (4.1% of total hemoglobin). The DHEA-S concentrations were highest in August-October and February-April (6.3 mol/L) and lowest in May-July and November-January (5.7 mol/L). The concentrations of total cholesterol (P Ͻ0.001), prolactin (P Ͻ0.001), and free testosterone (P ϭ 0.025) exhibited a cyclic variation with a period of 12 months. Total cholesterol was highest in January-March (5.4 mmol/L) and lowest in July-September (4.8 mmol/L), whereas prolactin was highest in March-May (153 mIU/L) and lowest in September-November (98 mIU/L). Free testosterone was highest in July-September (3.9 pmol/L) and lowest in January-March (3.0 pmol/L). The difference between the 3 months with the highest and the lowest concentrations was 12% for total cholesterol, 9% for DHEA-S, 7% for HbA 1c , 44% for prolactin, and 31% for free testosterone based on the predicted values. No seasonal effects were observed for IgA.
Average concentrations for three periods of the day are given for the measured physiological response variables together with data from repeated-measures GLM in Table  1 . A statistically significant within-day variation was demonstrated for concentrations of prolactin (P ϭ 0.044) and free testosterone (P ϭ 0.003). For both physiological response variables, the concentrations were highest in the morning. No diurnal variation was found for DHEA-S (P ϭ 0.37), whereas there was a tendency for IgA (P ϭ 0.059) to decrease during the day. Table 2 shows the overall average concentration for the group and range of individual averages, together with analytical (CV a ), within-subject (CV i ), and between-subject (CV g ) variability for the measured physiological response variables. CV i has been estimated for samples collected during 1 day (CV id ), during 1 month (CV im ) and during 1 year (CV iy ).
The CV a /CV iy ratio, the Ii, and prediction intervals for two samples from the same woman are given in Table 3 . The minimal detectable difference at a significance of ␣ ϭ 0.05 with the power P ϭ 1 Ϫ ␤ ϭ 0.80 is shown for group sizes of 1-100 in Fig. 3 .
Discussion
In the present study, the biological and analytical variations for total cholesterol, DHEA-S, IgA, prolactin, and free testosterone in serum together with HbA 1c in blood were examined because of their roles in response to psychosocial stress. Changes in these physiological response variables may potentially be associated with health impairment or disease. IgA is a general marker of the immune system, and DHEA-S and prolactin exhibit immunostimulating effects (16, 17 ) . Increased cholesterol concentrations in serum are related to risk for cardiovascular disease. Furthermore, some studies have indicated that low concentrations of anabolic hormones, e.g., testosterone and DHEA-S, and high concentrations of catabolic markers, e.g., HbA 1c , may be associated with increased risk of cardiovascular disease (18, 19 ) .
Concentrations of the anabolic hormones, DHEA-S and free testosterone, were found to be positively correlated in healthy women. A corresponding correlation has been found previously by others (20 ) . The correlation between DHEA-S and free testosterone in women may possibly be explained by a parallel excretion of DHEA-S, testosterone, and the testosterone precursor, androstenedione, because it has been reported previously that, in women, most of the DHEA-S and one-half of the testosterone and andro-stenedione originate from the adrenal cortex (21 ) . Moreover, concentrations of the anabolic hormone, DHEA-S, were negatively correlated with concentrations of HbA 1c , a marker for catabolic processes. The combina- tion of low anabolic activity and high catabolic activity may be indicative of increased risk of cardiovascular disease (19 ) .
Hormones and other physiological response variables measured in biological fluids often exhibit a multifrequency time structures with significant circadian or seasonal periodicity. Seasonal variations were demonstrated in healthy women for total cholesterol, DHEA-S, HbA 1c , prolactin, and free testosterone in the present study (Fig.  2) . Cholesterol concentrations are known to be affected by diet, which may offer an explanation for the seasonal variation (5 ) . Seasonal variation with a period length of 12 months has been reported previously for HbA 1c (22 ) . The low frequency of sampling in the previous study (four samples per individual per year) may explain the contrast to our finding of a period of 6 months. The seasonal variations in serum concentrations of DHEA-S and prolactin in the present study correspond to previous findings by others (5, 6, 23 ) . A seasonal variation of testosterone in men is well established, but seasonal variation has, to our knowledge, not been examined for free testosterone in healthy women. Circannual variation of total testosterone has been studied in women in three studies, one of which demonstrated a statistically significant seasonal variation (24 ) . However, no seasonal variation could be demonstrated in women for prolactin or total testosterone in two recent studies, both of which were conducted with a high degree of standardization, although there was a tendency for total testosterone to be highest in summer and autumn (5, 7 ) . The main differences from our study were the inclusion of postmenopausal women in the study groups together with ethnic and geographic differences. The finding of seasonal variation implies that standardizing the time of year for collection of samples must be considered when planning a study with measurement of these five physiological response variables. This is particularly important for prolactin where the difference between the seasonally highest and lowest concentrations was 44%.
A circadian rhythm has been described previously for prolactin and total testosterone in women (5 ) , which is in accordance with our findings of within-day variation for the two physiological response variables (Table 1) . For IgA, a circadian rhythm with maximal values in the early afternoon was documented in humans; however, Halberg et al. (25 ) found the highest concentration in the early afternoon, whereas we found a tendency for concentrations of IgA to decrease during the day. In the study by Nicolau et al. (5 ) , a circadian rhythm was demonstrated for DHEA-S in spring and summer but not in winter and autumn. Investigations were carried out with the same study group for all four seasons, indicating that the presence of a circadian rhythm for DHEA-S may depend on the season. Because the present study was carried out in the spring, the inability to find a circadian rhythm is more likely related to differences in sampling strategy, e.g., the number of hours per day or because the subjects in the present study were seated the whole day.
Concentrations of HbA 1c had very low within-subject variation ( Table 2 ). In fact, the CV ti based on measurement of samples collected within 1 month was less than CV a , and CV im was therefore estimated to be less than the upper limit of the 99% confidence interval for CV im . An explanation may be that the uncertainty of the estimates of CV ti and CV a were too high compared with the relatively small CV i .
The within-subject variation ( Table 2) for samples collected within 1 year for prolactin (CV iy ϭ 23%) demonstrated in this study was smaller than the corresponding within-subject variation, CV i ϭ 39.2%, found by Maes et al. (7 ) . The most likely reason is that the CV i found by Maes et al. (7 ) was estimated from data that were not logarithmically transformed. An analysis of our data without logarithmic transformation revealed a CV iy for prolactin of 39%. In the present study, the within-subject variation for total cholesterol for samples collected within 1 year (CV iy ϭ 5.5%) is similar to the within-subject variation (7.2%) reported by Costongs et al. (26 ) . We present new data for within-subject variation for healthy women for free testosterone and data over a longer time span (1 year) than studies compiled by Sebastian-Gambaro et al. (8 ) for DHEA-S, HbA 1c , IgA, and prolactin in healthy women.
The estimated within-subject variation may be used to set analytical goals for methods used for monitoring individual patients in clinical settings. It has been suggested that a desirable imprecision could be defined as CV a Ͻ 0.5(CV i ), and an optimum performance could be defined as CV a Ͻ 0.25(CV i ) (27 ) . In the present study, CV a /CV iy was Ͻ0.25 for methods for IgA and prolactin and Ͻ0.5 for total cholesterol and free testosterone. Thus, the analytical performance for these methods was adequate for clinical purposes. The CV a /CV iy for methods for DHEA-S and HbA 1c was Ͼ0.5, and a reduction in analytical variation appears desirable. However, both methods are within the criterion for minimum performance (CV a / CV i Ͻ 0.75); for HbA 1c the analytical variation was very low (CV a ϭ 1.8%), and it appears that for this analyte, the desirable performance standards are not obtainable with current technology and methodology.
The between-subject variations ( Table 2) for DHEA-S (CV g ϭ 21%) and prolactin (CV g ϭ 27%) found in our study are lower than the between-subject variation, 31% and 43-65%, respectively, presented by others (1, 7 ) . We present new data for healthy women for between-subject variation for free testosterone, CV g ϭ 29%. Previously, only data for total testosterone have been presented (CV g ϭ 26.9%) (1 ).
The Ii was Ͻ1.4 for all physiological response variables ( Table 3 ). According to a recent report by Petersen et al. (28 ) , this has no significance for the use of populationbased reference intervals, when a single measurement is evaluated. However, the low Ii makes it important to stratify populations to obtain separate reference intervals for subpopulations and to accumulate data from samples from the same individual where possible (28 ) .
The prediction intervals presented in Table 3 indicate the intervals within which the concentration of a physiological response variable in a future sample taken from the same woman is expected to be. For example, if a second sample taken from the same healthy woman within 1 year gives a result that is within 69 -145% of an earlier measurement of total cholesterol, it may simply reflect the underlying biological and analytical variation.
When planning a study on groups of individuals, larger groups are required when using a non-paired design compared with a paired design, if the same minimal detectable difference is desired (Fig. 3 ). This is partly because the between-subject variation is included in the power calculations for non-paired designs. The effect is observed when comparing the curves for IgA and total cholesterol. Although the same number of subjects are required for a given minimal detectable difference for a paired design, in a non-paired design, more subjects are required for measurement of IgA, which exhibits large between-subject variation compared with total cholesterol. Measurement of prolactin and free testosterone requires the largest number of subjects in each group for a given minimal detectable difference, mainly because of high biological variation for prolactin and high analytical variation for free testosterone.
In conclusion, in a study that includes physiological response variables on groups of individuals, optimal study design is important to reduce both the analytical and the biological variation. As shown in the present study, one way to reduce the biological variation is to restrict sample collection to specific hours of the day (prolactin and free testosterone) or times of the year (total cholesterol, DHEA-S, HbA 1c , prolactin, and free testoster-one) to avoid within-day and seasonal variation of the selected physiological response variables. However, such variation often has to be included in the study design. Correspondingly, the number of individuals in each group often is increased and a paired study design is chosen to obtain adequate statistical power.
